CymitQuimica logo

7-Hydroxy-4,8-dimethyl-2H-chromen-2-one

Ref. 3D-FH124560

2g
Discontinued
500mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

7-Hydroxy-4,8-dimethyl-2H-chromen-2-one
Biosynth

    Product Information

    Name:7-Hydroxy-4,8-dimethyl-2H-chromen-2-one
    Synonyms:
    • 2H-1-benzopyran-2-one
    • 7-hydroxy-4,8-dimethyl-
    Brand:Biosynth
    Description:7-Hydroxy-4,8-dimethyl-2H-chromen-2-one is a synthetic compound that has been shown to inhibit the growth of cancer cells. It can be used as a test compound for cancer research and development. 7-Hydroxy-4,8-dimethyl-2H-chromen-2-one inhibits the production of enzymes in the body by reacting with the methylene group of their active sites. This inhibition leads to less radical scavenging and an increase in reactive oxygen species (ROS) that can cause damage to cells. The reaction mechanism is not yet fully understood but it is known that this compound binds to chloride ions, which are necessary for enzyme activity. 7HMCD was synthesized by coupling methylene with coumarin derivatives and then reacting them with hydroxyl radicals. The enantiomers of 7HMCD have different optical properties, including absorption spectra and xray crystal structures.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:190.2 g/mol
    Formula:C11H10O3
    Purity:Min. 95%
    InChI:InChI=1S/C11H10O3/c1-6-5-10(13)14-11-7(2)9(12)4-3-8(6)11/h3-5,12H,1-2H3
    InChI key:InChIKey=MVMMGVPSTRNMSV-UHFFFAOYSA-N
    SMILES:Cc1cc(=O)oc2c(C)c(O)ccc12

    Inquiry about discontinued product: 7-Hydroxy-4,8-dimethyl-2H-chromen-2-one

    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.